OUR IMPACT Osteoporosis Canada’s latest Impact Report is now available. This report highlights the organization’s significant achievements over the past year towards the vision of a Canada without osteoporotic fractures. […]

We are aware of recent press reports concerning the link between two drugs for osteoporosis (alendronate and zoledronate) and the occurrence of a heart condition characterized by an irregular heart […]